Khả Năng Kháng In Vitro của Rhodococcus equi và Các Tác Nhân Thường Gặp Ở Ngựa Đối Với Azithromycin, Clarithromycin và 20 Chất Kháng Khuẩn Khác
Tóm tắt
Mục tiêu của nghiên cứu này là xác định hoạt tính in vitro của azithromycin (AZM), clarithromycin (CLR) và 20 chất kháng khuẩn khác chống lại
Từ khóa
#Kháng thuốc; Rhodococcus equi; Azithromycin; Clarithromycin; Ngựa; Kháng sinhTài liệu tham khảo
Adamson, P. J., W. D. Wilson, D. C. Hirsh, J. D. Baggot, and L. D. Martin. 1985. Susceptibility of equine bacterial isolates to antimicrobial agents. Am. J. Vet. Res.46:447-450.
Ainsworth, D. M., S. W. Eicker, A. E. Yeagar, C. R. Sweeney, L. Viel, D. Tesarowski, J. P. Lavoie, A. Hoffman, M. R. Paradis, S. M. Reed, H. N. Erb, E. Davidow, and M. Nalevanko. 1998. Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992). J. Am. Vet. Med. Assoc.213:510-515.
Burrows, G. E., R. J. Morton, and W. H. Fales. 1993. Microdilution antimicrobial susceptibilities of selected gram-negative veterinary bacterial isolates. J. Vet. Diagn. Investig.5:541-547.
Davis, J. L., S. Y. Gardner, S. L. Jones, B. A. Schwabenton, and M. G. Papich. 2002. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. J. Vet. Pharmacol. Ther.25:99-104.
Ensink, J. M., B. van Klingeren, D. J. Houwers, W. R. Klein, and A. G. Vulto. 1993. In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands. Equine Vet. J.25:309-313.
Harvey, R. L., and J. C. Sunstrum. 1991. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev. Infect. Dis.13:139-145.
Jacks, S., S. Giguère, R. R. Gronwall, M. P. Brown, and K. A. Merritt. 2002. Disposition of oral clarithromycin in foals. J. Vet. Pharmacol. Ther.25:359-362.
Lakritz, J., W. D. Wilson, and J. E. Mihalyi. 1999. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. Am. J. Vet. Res.60:414-419.
National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. NCCLS document M7-A4. 1997. National Committee for Clinical Laboratory Standards Wayne Pa.
National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standards. NCCLS document M31-A. National Committee for Clinical Laboratory Standards Wayne Pa.
Nordmann, P., and E. Ronco. 1992. In-vitro antimicrobial susceptibility of Rhodococcus equi. J. Antimicrob. Chemother.29:383-393.
Soriano, F., R. Fernandez-Roblas, R. Calvo, G. Garcia-Calvo, M. Pardeiro, and A. Bryskier. 1998. In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens. J. Antimicrob. Chemother.42:647-649.
Sweeney, C. R., R. W. Sweeney, and T. J. Divers. 1987. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet. Microbiol.14:329-336.